Stuart A Arbuckle Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Stuart A Arbuckle.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Stuart A Arbuckle. Stuart A Arbuckle is Director in IMMUNOGEN INC ($IMGN) and EVP, Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP\Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Cerulean Pharma Inc. ($CERU) and Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM).

Stuart A Arbuckle in VERTEX PHARMACEUTICALS INC / MA

Trading Symbol: VRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: EVP, Chief Commercial Officer, EVP\Chief Commercial Officer
Holdings: 44,737 shares
Current Value: $3,884,961
Latest Transaction: Feb 26 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Stuart A Arbuckle in VERTEX PHARMACEUTICALS INC / MA

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, DARE, IMGN, RYTM, VRTX

Page: 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	216.57	254	55,009	41,103	41.4 K to 41.1 K (-0.61 %)
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	215.62	300	64,686	41,357	41.7 K to 41.4 K (-0.72 %)
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	214.32	400	85,728	41,657	42.1 K to 41.7 K (-0.95 %)
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	213.55	1,400	298,970	42,057	43.5 K to 42.1 K (-3.22 %)
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	212.52	900	191,268	43,457	44.4 K to 43.5 K (-2.03 %)
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	211.39	380	80,328	44,357	44.7 K to 44.4 K (-0.85 %)
Feb 26 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	217.57	2,898	630,518	44,737	47.6 K to 44.7 K (-6.08 %)
Feb 19 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	213.26	100	21,326	47,635	47.7 K to 47.6 K (-0.21 %)
Feb 19 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	212.49	2,763	587,110	47,735	50.5 K to 47.7 K (-5.47 %)
Feb 19 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	211.77	3,940	834,374	50,498	54.4 K to 50.5 K (-7.24 %)
Feb 19 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	210.05	1,022	214,671	54,438	55.5 K to 54.4 K (-1.84 %)
Feb 19 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	211.75	6,240	1,321,320	55,460	61.7 K to 55.5 K (-10.11 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,554	134,452	0
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	216.83	89	19,298	69,957	70 K to 70 K (-0.13 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	215.80	90	19,422	70,046	70.1 K to 70 K (-0.13 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	214.98	242	52,025	70,136	70.4 K to 70.1 K (-0.34 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	213.90	497	106,308	70,378	70.9 K to 70.4 K (-0.70 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	212.77	488	103,832	70,875	71.4 K to 70.9 K (-0.68 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	211.22	148	31,261	71,363	71.5 K to 71.4 K (-0.21 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	86.52	1,554	134,452	71,511	70 K to 71.5 K (+2.22 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	13,952	0	69,957	56 K to 70 K (+24.91 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	12,388	0	56,005	43.6 K to 56 K (+28.40 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,554	134,452	0
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	8,438	0	43,617	35.2 K to 43.6 K (+23.99 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	216.83	89	19,298	69,957	70 K to 70 K (-0.13 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	215.80	90	19,422	70,046	70.1 K to 70 K (-0.13 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	214.98	242	52,025	70,136	70.4 K to 70.1 K (-0.34 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	213.90	497	106,308	70,378	70.9 K to 70.4 K (-0.70 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	212.77	488	103,832	70,875	71.4 K to 70.9 K (-0.68 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	211.22	148	31,261	71,363	71.5 K to 71.4 K (-0.21 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	86.52	1,554	134,452	71,511	70 K to 71.5 K (+2.22 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	13,952	0	69,957	56 K to 70 K (+24.91 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	12,388	0	56,005	43.6 K to 56 K (+28.40 %)
Feb 05 2021	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	8,438	0	43,617	35.2 K to 43.6 K (+23.99 %)
Nov 18 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	224.11	5	1,121	35,179	35.2 K to 35.2 K (-0.01 %)
Nov 18 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	222.47	2	445	35,184	35.2 K to 35.2 K (-0.01 %)
Nov 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,553	134,366	1,554
Nov 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	214.13	334	71,519	35,179	35.5 K to 35.2 K (-0.94 %)
Nov 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	212.38	245	52,033	35,513	35.8 K to 35.5 K (-0.69 %)
Nov 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	211.54	487	103,020	35,758	36.2 K to 35.8 K (-1.34 %)
Nov 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	210.56	487	102,543	36,245	36.7 K to 36.2 K (-1.33 %)
Nov 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	86.52	1,553	134,366	36,732	35.2 K to 36.7 K (+4.41 %)
Aug 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,553	134,366	3,107
Aug 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	279.58	280	78,282	35,179	35.5 K to 35.2 K (-0.79 %)
Aug 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	278.72	689	192,038	35,459	36.1 K to 35.5 K (-1.91 %)
Aug 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	277.85	413	114,752	36,148	36.6 K to 36.1 K (-1.13 %)
Aug 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	276.40	171	47,264	36,561	36.7 K to 36.6 K (-0.47 %)
Aug 05 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	86.52	1,553	134,366	36,732	35.2 K to 36.7 K (+4.41 %)
Jul 09 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	155.57	1,222	190,107	8,561
Jul 09 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	187.53	1,564	293,297	17,206
Jul 09 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	300.00	2,786	835,800	35,179	38 K to 35.2 K (-7.34 %)
Jul 09 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	155.57	1,222	190,107	37,965	36.7 K to 38 K (+3.33 %)
Jul 09 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	187.53	1,564	293,297	36,743	35.2 K to 36.7 K (+4.45 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	288.35	9	2,595	35,179	35.2 K to 35.2 K (-0.03 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	287.62	24	6,903	35,188	35.2 K to 35.2 K (-0.07 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	286.41	21	6,015	35,212	35.2 K to 35.2 K (-0.06 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	285.00	10	2,850	35,233	35.2 K to 35.2 K (-0.03 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	283.58	10	2,836	35,243	35.3 K to 35.2 K (-0.03 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	280.71	12	3,369	35,253	35.3 K to 35.3 K (-0.03 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	279.93	17	4,759	35,265	35.3 K to 35.3 K (-0.05 %)
May 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	276.35	10	2,764	35,282	35.3 K to 35.3 K (-0.03 %)
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,553	134,366	4,660
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	264.89	113	29,933	35,179	35.3 K to 35.2 K (-0.32 %)
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	262.54	240	63,010	35,292	35.5 K to 35.3 K (-0.68 %)
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	261.34	240	62,722	35,532	35.8 K to 35.5 K (-0.67 %)
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	260.32	320	83,302	35,772	36.1 K to 35.8 K (-0.89 %)
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	259.36	640	165,990	36,092	36.7 K to 36.1 K (-1.74 %)
May 06 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	86.52	1,553	134,366	36,732	35.2 K to 36.7 K (+4.41 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.33	632	150,625	35,179	35.8 K to 35.2 K (-1.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	236.88	20	4,738	35,811	35.8 K to 35.8 K (-0.06 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	236.36	420	99,271	35,831	36.3 K to 35.8 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	235.14	540	126,976	36,251	36.8 K to 36.3 K (-1.47 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	234.08	420	98,314	36,791	37.2 K to 36.8 K (-1.13 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	232.35	360	83,646	37,211	37.6 K to 37.2 K (-0.96 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	230.85	432	99,727	37,571	38 K to 37.6 K (-1.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	229.78	810	186,122	38,003	38.8 K to 38 K (-2.09 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	239.23	2,898	693,289	38,813	41.7 K to 38.8 K (-6.95 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.76	377	92,652	41,711	42.1 K to 41.7 K (-0.90 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.04	580	142,123	42,088	42.7 K to 42.1 K (-1.36 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	243.76	400	97,504	42,668	43.1 K to 42.7 K (-0.93 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.91	1,011	245,582	43,068	44.1 K to 43.1 K (-2.29 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.08	760	183,981	44,079	44.8 K to 44.1 K (-1.69 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	241.50	2,496	602,784	44,839	47.3 K to 44.8 K (-5.27 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	248.62	486	120,829	47,335	47.8 K to 47.3 K (-1.02 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	247.91	1,863	461,856	47,821	49.7 K to 47.8 K (-3.75 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	246.76	1,770	436,765	49,684	51.5 K to 49.7 K (-3.44 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.93	3,377	830,506	51,454	54.8 K to 51.5 K (-6.16 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	244.99	2,860	700,671	54,831	57.7 K to 54.8 K (-4.96 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	243.76	930	226,697	57,691	58.6 K to 57.7 K (-1.59 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	240.95	8,942	2,154,575	58,621	67.6 K to 58.6 K (-13.24 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	155.57	1,223	190,262	9,783
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	187.53	1,564	293,297	18,770
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.47	171	41,462	67,563	67.7 K to 67.6 K (-0.25 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	241.08	150	36,162	67,734	67.9 K to 67.7 K (-0.22 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	240.53	230	55,322	67,884	68.1 K to 67.9 K (-0.34 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	239.47	725	173,616	68,114	68.8 K to 68.1 K (-1.05 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.71	1,511	360,691	68,839	70.4 K to 68.8 K (-2.15 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	155.57	1,223	190,262	70,350	69.1 K to 70.4 K (+1.77 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	187.53	1,564	293,297	69,127	67.6 K to 69.1 K (+2.31 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	12,387	0	67,563	55.2 K to 67.6 K (+22.45 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	9,800	0	55,176	45.4 K to 55.2 K (+21.60 %)
Feb 07 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Grant	A	0.00	12,136	0	45,376	33.2 K to 45.4 K (+36.51 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	86.52	1,554	134,452	6,213
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	91.05	2,156	196,304	0
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Option Exercise	M	187.53	4,692	879,891	20,334
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	232.71	540	125,663	33,240	33.8 K to 33.2 K (-1.60 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	231.87	900	208,683	33,780	34.7 K to 33.8 K (-2.60 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	231.16	1,300	300,508	34,680	36 K to 34.7 K (-3.61 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	229.99	530	121,895	35,980	36.5 K to 36 K (-1.45 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	228.90	440	100,716	36,510	37 K to 36.5 K (-1.19 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	M	86.52	1,554	134,452	36,950	38.5 K to 37 K (-4.04 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	M	91.05	2,156	196,304	35,396	37.6 K to 35.4 K (-5.74 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.65	4,692	1,119,746	33,240	37.9 K to 33.2 K (-12.37 %)
Feb 04 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Buy	M	187.53	4,692	879,891	37,932	33.2 K to 37.9 K (+14.12 %)
Nov 15 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	155.57	8,560	1,331,679	11,006
Nov 15 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	205.57	8,560	1,759,679	33,240	41.8 K to 33.2 K (-20.48 %)
Nov 15 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	155.57	8,560	1,331,679	41,800	33.2 K to 41.8 K (+25.75 %)
Nov 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	86.52	1,553	134,366	7,767
Nov 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	91.05	2,155	196,213	2,156
Nov 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	201.62	1,553	313,116	33,240	34.8 K to 33.2 K (-4.46 %)
Nov 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	86.52	1,553	134,366	34,793	33.2 K to 34.8 K (+4.67 %)
Nov 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	201.62	2,155	434,491	33,240	35.4 K to 33.2 K (-6.09 %)
Nov 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	91.05	2,155	196,213	35,395	33.2 K to 35.4 K (+6.48 %)
Aug 12 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	131.89	2,125	280,266	0
Aug 12 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	181.89	2,125	386,516	33,240	35.4 K to 33.2 K (-6.01 %)
Aug 12 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	131.89	2,125	280,266	35,365	33.2 K to 35.4 K (+6.39 %)
Aug 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	86.52	1,553	134,366	9,320
Aug 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	91.05	2,155	196,213	4,311
Aug 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	176.44	1,553	274,011	32,240	33.8 K to 32.2 K (-4.60 %)
Aug 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	86.52	1,553	134,366	33,793	32.2 K to 33.8 K (+4.82 %)
Aug 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	177.78	2,155	383,116	32,240	34.4 K to 32.2 K (-6.27 %)
Aug 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	91.05	2,155	196,213	34,395	32.2 K to 34.4 K (+6.68 %)
Jun 20 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	131.89	2,125	280,266	2,125
Jun 20 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	181.89	2,125	386,516	33,240	35.4 K to 33.2 K (-6.01 %)
Jun 20 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	131.89	2,125	280,266	35,365	33.2 K to 35.4 K (+6.39 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	86.52	1,553	134,366	10,873
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	91.05	2,155	196,213	6,466
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	173.60	593	102,945	33,240	33.8 K to 33.2 K (-1.75 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	172.73	400	69,092	33,833	34.2 K to 33.8 K (-1.17 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	171.31	320	54,819	34,233	34.6 K to 34.2 K (-0.93 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	170.28	240	40,867	34,553	34.8 K to 34.6 K (-0.69 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	86.52	1,553	134,366	34,793	33.2 K to 34.8 K (+4.67 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	171.70	100	17,170	33,240	33.3 K to 33.2 K (-0.30 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	170.72	400	68,288	33,340	33.7 K to 33.3 K (-1.19 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	169.31	457	77,375	33,740	34.2 K to 33.7 K (-1.34 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	168.56	1,198	201,935	34,197	35.4 K to 34.2 K (-3.38 %)
May 06 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	91.05	2,155	196,213	35,395	33.2 K to 35.4 K (+6.48 %)
Apr 17 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	183.61	320	58,755	33,240	33.6 K to 33.2 K (-0.95 %)
Apr 17 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	182.29	2,712	494,370	33,560	36.3 K to 33.6 K (-7.48 %)
Apr 17 2019	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	180.95	2,592	469,022	36,272	38.9 K to 36.3 K (-6.67 %)

Page: 1 2 3 next >